Cases & Deals

Cytheris places shares with investor group

Clients Cytheris S.A.

Jones Day advised Cytheris S.A., a privately held clinical-stage biopharmaceutical company, in connection with its issuance of €24.3 million ($30.7 million) of Series B Convertible Preferred Stock in a private placement to CDC Enterprises Innovation, ABN AMRO Capital Life Sciences, AXA Private Equity, BIOAM/Bioamgestion, Crédit Agricole Private Equity, T2C2/Bio 2000, and Caisse de Dépôt et Placement du Québec.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.